Your browser doesn't support javascript.
loading
A comparison of preliminary oncologic outcome and postoperative complications between patients undergoing either open or robotic radical cystectomy
Cusano, Antonio; Haddock, Peter; Jackson, Max; Staff, Ilene; Wagner, Joseph; Meraney, Anoop.
  • Cusano, Antonio; Hartford Healthcare Medical Group. Urology Division. Hartford. US
  • Haddock, Peter; Hartford Healthcare Medical Group. Urology Division. Hartford. US
  • Jackson, Max; Hartford Healthcare Medical Group. Urology Division. Hartford. US
  • Staff, Ilene; Hartford Healthcare Medical Group. Urology Division. Hartford. US
  • Wagner, Joseph; Hartford Healthcare Medical Group. Urology Division. Hartford. US
  • Meraney, Anoop; Hartford Healthcare Medical Group. Urology Division. Hartford. US
Int. braz. j. urol ; 42(4): 663-670, July-Aug. 2016. tab
Article in English | LILACS | ID: lil-794684
ABSTRACT
ABSTRACT

Purpose:

To compare complications and outcomes in patients undergoing either open radical cystectomy (ORC) or robotic-assisted radical cystectomy (RRC). Materials and

Methods:

We retrospectively identified patients that underwent ORC or RRC between 2003- 2013. We statistically compared preliminary oncologic outcomes of patients for each surgical modality.

Results:

92 (43.2%) and 121 (56.8%) patients underwent ORC and RRC, respectively. While operative time was shorter for ORC patients (403 vs. 508 min; p<0.001), surgical blood loss and transfusion rates were significantly lower in RRC patients (p<0.001 and 0.006). Length of stay was not different between groups (p=0.221). There was no difference in the proportion of lymph node-positive patients between groups. However, RRC patients had a greater number of lymph nodes removed during surgery (18 vs. 11.5; p<0.001). There was no significant difference in the incidence of pre-existing comorbidities or in the Clavien distribution of complications between groups. ORC and RRC patients were followed for a median of 1.38 (0.55-2.7) and 1.40 (0.582.59) years, respectively (p=0.850). During this period, a lower proportion (22.3%) of RRC patients experienced disease recurrence vs. ORC patients (34.8%). However, there was no significant difference in time to recurrence between groups. While ORC was associated with a higher all-cause mortality rate (p=0.049), there was no significant difference in disease-free survival time between groups.

Conclusions:

ORC and RRC patients experience postoperative complications of similar rates and severity. However, RRC may offer indirect benefits via reduced surgical blood loss and need for transfusion.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Postoperative Complications / Urinary Bladder Neoplasms / Cystectomy / Robotic Surgical Procedures Type of study: Incidence study / Observational study / Prognostic study / Risk factors Limits: Aged / Female / Humans / Male Country/Region as subject: North America Language: English Journal: Int. braz. j. urol Journal subject: Urology Year: 2016 Type: Article Affiliation country: United States Institution/Affiliation country: Hartford Healthcare Medical Group/US

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Postoperative Complications / Urinary Bladder Neoplasms / Cystectomy / Robotic Surgical Procedures Type of study: Incidence study / Observational study / Prognostic study / Risk factors Limits: Aged / Female / Humans / Male Country/Region as subject: North America Language: English Journal: Int. braz. j. urol Journal subject: Urology Year: 2016 Type: Article Affiliation country: United States Institution/Affiliation country: Hartford Healthcare Medical Group/US